Ontario-based RedeCan Pharm was announced as the newest, fully licensed to sell producer under the MMPR on March 25th. The family-run operation, located in the Niagara region, is approximately 15,000 square feet of "primarily hydroponic" greenhouse production space and has 30 years of agricultural experience.
RedeCan becomes the 17th Licensed Producer fully-authorized to sell medical marijuana in Canada under the Marihuana for Medical Purposes Regulation after being approved to produce (grow) in June 2014.
Unlike many other producers, RedeCan has kept a relatively low profile. The company has had no social media presence, and only a landing page for their website at RedeCanPharm.ca as they've taken a 'head down' approach, focusing on their production and approval process more than marketing.
"Really, there were no deep reasons for keeping a low profile," says Rick Redekop, the company's head of operations. "We are a family owned business and had our hands full juggling many jobs at the same time. We did everything ourselves without outside help or funding so we were very preoccupied. Our focus was on growing a quality product for our patients and meeting Health Canada's regulations.
"We did not have the sales license therefore there was no reason to advertise. We were actually the only LP that didn't receive a warning letter in regards to advertising. We just didn't want to make or receive any hype until we were in a position to make sales. "
RedeCan Pharm is using "common variety names" that seed producers would use rather than choosing to come up with new names, as other producers have done.
"We feel that people can more easily relate to these names and varieties than a re-branded name," says Redekop. "In addition, it makes it easier for a patient to look up additional information on a particular strain and what they are beneficial for."
We did everything ourselves without outside help or funding... Our focus was on growing a quality product for our patients and meeting Health Canada's regulations." Rick Redekop
The first strains available are Diesel, OG Kush, Moby Dick, Strawberry Cough, Blue Widow, White Widow, and Shaman. 6 other strains will be made available for sale in the near future. There will also be alternate varieties available by the end of June. Varieties can be found at www.redecanpharm.ca
The company hopes to keep pricing between $5 and $7 per gram, and will be looking at forming a 'compassion pricing' program in the future, depending on patients' needs and feedback.
While a relatively small-sized producer, Redekop feels confident RedeCan is more than ready to assist patients in finding the right strains for them. The long road to full approval is only the first stage in becoming a successful cannabis producer in Canada, but they are happy to be through it.
"The mood around here is one of excitement," says Rick. "We have done the whole process solely as a family, and it has been a long road for the four of us to get to where we are. All our efforts have gone into growing the product, following the rules of Health Canada. We are just really happy that we have made it to this point and are excited about the future of our business and what it means to patient care."
More on RedeCan from Lift over the coming weeks.